BMS-986482

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986482, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing